Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation

Table 1 Neuroinflammation-related cognitive disorders treated with mesenchymal stem cells

Neurological pathology	Ref.
Hemorrhage-induced brain injury (stroke)	Chang et al[42], 2014
	Liu et al[60], 2019
Traumatic brain injury	Tsai et al[75], 2011
Post-operative inflammatory syndrome	Sun et al[62], 2020
Experimental autoimmune encephalomyelitis	Vigo et al[61], 2021
Major depressive disorder	Gallagher et al[63], 2019
Schizophrenia-relevant behavior	You et al[64], 2020
Neurodegenerative diseases	Sakthiswary and Raymond[37], 2012
	Kim et al[43], 2013
	Fan et al[44], 2014
	Zhang et al[65], 2020
AD models	Lee et al[39], 2012
	Yang et al[41], 2013
	Lee et al[45], 2009
	Lee et al[46], 2010
	Bae et al[47], 2013
	Zhang et al[48], 2012
	Salem et al[49], 2018
	Danielyan et al[50], 2014
	Ma et al[51], 2013
	Chang et al[52], 2014
	Yan et al[53], 2014
	Bobkova et al[54], 2013
	Yun et al[55], 2013
	Zheng et al[56], 2017
	Bian et al[57], 2017
	Kim et al[66], 2020
	Farahzadi et al[67], 2020
	Dando et al[82], 2014
PD models	Chen et al[68], 2020
	Bi et al[69], 2020
Huntington disease	Yu-Taeger et al[70], 2019

AD: Alzheimer diseases; PD: Parkinson diseases.